The.ability to construct a fine-structure map ofthe human~chro-mosomes at the DNA level would have many important practical and theoretical implications for human genetics (1) (2) (3) . The work of our group has focused.on human chromosome 11 as a model system in pursuit ofthis goal. Previously, we isolated and characterized a human-Chinese hamster ovary, (CHO) hybrid cell containing only human chromosome 11.(4) . We identified several genes coding for cell surface antigens carried by this chromosome (5) (6) (7) (8) and, using selection against.these markers, we derived a series of hybrid cells in which varying portions of the chromosome have been deleted (1, 2, .8) . The isozyme markers lactate dehydrogenase A (LDHA) and acid phosphatase-2 (ACP2) were mapped to specific regions of the short arm of human chromosome 11 by using these hybrid cells (1) .
This analysis was then extended by the application of recombinant DNA technology to the problem of the fine structure of human chromosome 11. Initially we mapped the human f3-globin gene. complex to a specific subregion of the chromosome (2) . Subsequently, we developed a. general technique for the preparation of a library of DNA segments of the single human chromosome in such hybrid cells and proceeded to map the. DNA segments isolated by this technique to subregions of the chromosome (1) .
The current study is a further development of this approach, demonstrating that, by the use ofa repetitive sequence that occurs on human chromosome 11, even greater effectiveness can be achieved in the genetic mapping.of the chromosome. It is shown that this technique can identify deletions with precision and achieve more-exact location of particular markers than previously was possible.
Families of repeated DNA sequences are interspersed throughout the human genome adjacent to single-copy DNA sequences. Digestion of the DNA of human chromosome 11 with a restriction enzyme that does not cleave at more than two sites within such a repeated DNA sequence will. generate .a unique pattern of DNA fragments of. various sizes, each containing at least one repeat unit of such a sequence. When these DNA fragments are fractionated by agarose gel electrophoresis, transferred to nitrocellulose by the Southern blotting procedure (9) , and hybridized to the labeled repeated DNA segment, a characteristic set of DNA fragments of various sizes results. When. this array of fragments from a normal chromosome is compared with a similar array from a chromosome that has suffered deletions, the latter array should reveal an altered, gel electrophoretic pattern because of the disappearance ofspecific fragments of characteristic sizes.
In. the study reported in this paper, a repeated DNA sequence that occurs approximately 2,000 times in the human genome has been used as a probe to explore the structures of a panel of hybrids containing altered forms of human chromosome 11. A method of analysis described here permits generation ofa detailed map ofthis chromosome and determination of the changes in specific mutants. This approach promises appreciable extension of the powers of mapping mammalian genomes.
MATERIALS AND METHODS
Preparation and properties of the CHO hybrids containing a single human.chromosome have been.described (4) , along with the.use of cell surface antigenic loci on human chromosome 11 as selective markers for isolation ofa battery of hybrid cells containing deletion mutants of this chromosome (5, 6) .. DNA was prepared from these cell lines as described (2) .
In previous publications we designated the human-CHO hybrid containing the single human chromosome. 11 as the AL hybrid (4, 7, 10 SAil-i, -2, and -3) have been shown to derive from loci.on chromosome 11, a, and a3 being on the-short and a2 on the long arm (5, 10) .
Digestion of cellular DNA with EcoRI, agarose gel electrophoresis, Southern EXPERIMENTAL RESULTS Several repeated DNA sequences that have previously been described in the region ofthe ,3-globin gene complex by various investigators were tested for their potential utility in mapping studies of chromosome 11. The map of these segments as they occur adjacent to the human -y-globin genes is shown in Fig.  1 . In preliminary experiments, the repeated DNA sequences designated TEG C, TEG D, and A36Fc, which had been subcloned in the plasmid vector pBR328, were used as probes in the Southern transfer procedure against DNA isolated from a somatic cell-CHO hybrid line containing the single human chromosome 11 (1, 2) . Under the conditions used in these experiments, these repeated human DNA sequences display no detectable cross-hybridization to CHO DNA and, therefore, all the hybridization observed must involve human DNA sequences from chromosome 11. When TEG C and TEG D were used as hybridization probes to EcoRI-digested DNA from the AL-J1 hybrid, the pattern of hybridization observed was too complex to be useful, but the A36Fc sequence furnished a hybridization pattern that included at least 24 discrete, readily identifiable DNA fragments in an EcoRI digest of AL-J1 DNA.
The A36Fc probe of 2.2 kilobases (kb) shown in Fig. 1 Because all the mutant clones examined lost several markers, it is presumed that they underwent deletional events. Knowing that the a, and a3 genes are on the short arm and a2 is on the long arm of chromosome 11 (10) makes it possible to carry out a mapping procedure for all ofthe other markers without further reference to cytogenetic data. For example, AL-J1-21 lost the smallest number of markers, including a, and a3. Assume this clone to have suffered a single mutational event-i.e., a terminal deletion ofthe short arm. The mutant clone with the next larger number of marker losses will also be considered to have undergone a single terminal deletion at a point further from the telomere, provided that it includes all of the losses of AL-J1-21 and does not possess an excessive number of additional losses. Similarly, mutants with successively larger marker losses which include all those of the preceding mutant will be considered to have suffered still larger terminal deletions, provided that the number of losses does not exceed those ofits immediate predecessor by more than two or three markers. Fragments were numbered in order of decreasing size. Only those fragments that hybridized intensely or that were located in regions of the gel that allowed them to be monitored reproducibly were included in this analysis, and only these are given numbers. Proc. Natl. Acad. Sci. USA 79 (1982) 7807 to the order of increasing size of the terminal deletion of the short arm ( Table 2 ). The order of the clones of group I defines a consistent linear order of the markers on the short arm of the chromosome. Group II, the group ofclones that appear to have retained all the markers ofthe short arm but to have lost a2 and, therefore, to have suffered a single terminal deletion in the long arm of chromosome 11, is represented so far by only a single clone, AL-Ji-l. The final three mutants do not fit a pattern of single deletion events. All have lost markers from both chromosome arms and have suffered many more marker losses than the mutants in group I or II. These clones which have undergone multiple deletions are then placed in group III. The markers 16, 7, /3-globin, and 9 appear to be contiguous in ALUJ1-4B, which has suffered a deletional event in each arm. The mutant AL-Jl-LOA also appears to have undergone a terminal deletion in each arm but has retained the markers 7, /3-globin, 9, and 6, confirming the order ofthe first three markers and suggesting that fragment 6 resides below the long arm break point ofAL-J1-4B. The data are consistent with the placement ofmarker 16 distal to the short arm break point ofAL-J1-10A. It is noteworthy that these clones which appear to involve two deletional events were prepared by two separate mutagenic treatments. The pattern of markers observed in the AL-J1-10A cell line involves loss of a number of long-arm markers without any additional losses of the shortarm markers present in AL-JI-10. This pattern suggests that the former hybrid cell line was the result of two terminal deletion events, the first in the short arm and the second in the long arm.
A final mutant that appears to have undergone multiple events is AL-J1-1 which retains only fragment 7 and f-globin. Because the A36Fc probe was derived from an EcoRI fragment The present analysis which is almost completely independent of cytogenetics can be compared with other cytogenetic data as a test of its validity. Cytogenetic analysis confirms the conclusions reached here that clones AL-J1-8, -7, -10, and -23 contain terminal deletions of the short arm and that AL-Ji-11 has a tervinal deletion ofthe long arm of human chromosome 11. Clone AL-J1-1 fails to display any recognizable human chromosomal material and may represent a small insertion of the segment containing 7 and P-globin into a CHO chromosome. Clone AL-J14B contains a very small human chromosomal fragment which appears to be a centromeric fragment and offers independent confirmation ofthe location offragment 9 in the region of the centromere. Proc. Nati. Acad. Sci. USA 79 (1982) DISCUSSION This approach makes possible simultaneous preparation and mapping of large numbers of DNA fragments from a single human chromosome. A panel of deletion mutants is generated by minimal exposure of a hybrid cell containing a single human chromosome to deletion-producing mutagens and selection for loss of particular markers. DNA from the original hybrid and each of these deletion mutants is digested with a restriction enzyme; the fragments are fractionated by agarose gel electrophoresis, transferred to nitrocellulose, and hybridized to a lowcopy, interspersed, repetitive, human DNA probe to detect fragments containing copies of the repeated sequence. The presence or absence of each marker fragment along with any other available biochemical markers is scored in each mutant and a table is constructed in which the various deletion mutants are ordered. The mutant that has lost the fewest markers is considered to have suffered a single terminal deletion from a single arm. The mutant that has lost all of the same markers as this clone plus the smallest number of additional markers is considered to have suffered the next largest terminal deletion from this arm. Proceeding in this way, the order ofmutants that have undergone progressively larger terminal deletions from individual arms is established for each of the biochemical, immunological, and DNA fragment markers used. Mutants that have undergone terminal deletions from both arms can be identified by loss of markers in the proper order from each arm. Finally, cytogenetic analysis confirms the order of the larger deletions and helps fix the position of the centromere.
The method described here can be applied to additional human chromosomes because various single human chromosome hybrids have been described, and presumably more can be prepared (4, 5, (10) (11) (12) (13) (14) . The resolving power of this approach can be materially increased by preparation of many more deletion mutants which have lost selective markers, development of new selective markers such as receptors for toxic drugs, and use of additional DNA probes (1, 15) and restriction enzymes. Localization of a particular copy of a repeated DNA sequence can provide an entry point to a particular region of interest (1) . Once the appropriate repetitive sequence is cloned, the singlecopy flanking sequences can be used as probes to isolate additional segments of DNA from the same region, to identify polymorphism and mutation in DNA sequences (16) (17) (18) (19) , to identify chromosomal rearrangements, and to study defects responsible for human disease.
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